XM does not provide services to residents of the United States of America.

IBM sues Take-Two for patent infringement over internet technology



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>IBM sues Take-Two for patent infringement over internet technology</title></head><body>

By Blake Brittain

Sept 30 -IBM IBM.N sued video-game maker Take-Two Interactive TTWO.O in Delaware federal court on Monday for allegedly violating its patent rights covering a range of internet-related technology.

IBM said in its lawsuit that a Take-Two game launcher and entries from its popular NBA 2K, Grand Theft Auto and Red Dead Redemption series infringe IBM patents related to web advertising, virtual worlds and user authentication.

Spokespeople for Take-Two and attorneys and spokespeople for IBM did not immediately respond to requests for comment on the lawsuit.

Armonk, N.Y.-based IBM has targeted other companies with infringement lawsuits over similar technology, some of which it developed for its late-1980s internet service Prodigy.

IBM resolved a related case against pet food seller Chewy in March and settled with Japanese tech company Rakuten in June for an undisclosed amount. Online marketplace Groupon settled IBM's lawsuit against it for $57 million in 2018 following an $83 million jury verdict in IBM's favor.

IBM won a $45 million jury verdict in Delaware against mobile game maker Zynga over related patents earlier this month. Take-Two acquired Zynga in 2022.

IBM's lawsuit against New York-based Take-Two said that the companies discussed the alleged infringement since 2021 and that IBM "invited Take-Two to engage in meaningful discussions towards a licensing resolution" earlier this year.

"Rather than engaging IBM in productive business discussions, Take-Two instead chose to continue to support Zynga's efforts to avoid culpability for its willful infringement," IBM's complaint said.

The case is International Business Machines Corp v. Take-Two Interactive Software Inc, U.S. District Court for the District of Delaware, No. 1:24-cv-01087.

For IBM: John Desmarais, Karim Oussayef, Tamir Packin and Brian Matty of Desmarais

For Take-Two: Not yet available

Read more:

IBM wins $45 mln verdict against Zynga in internet tech patent trial



Reporting by Blake Brittain in Washington

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.